Table 1.

Summary of patient demographics.

	Control	UC
Patients [n]	35	27
Mayo endoscopy subscore [n]:
0		0
1		6
2		16
3		5
Gender: male/female [n]	19/16	17/10
Mean age at biopsy, years [range]	55 [21–77]	45 [19–73]
Mean duration of disease, years [range]		9.8 [0.2–33]
Concomitant IBD medications [n]
Anti-TNF [infliximab, adalimumab]		0
Anti-leukocyte trafficking [etrolizumab, vedolizumab, natalizumab]		0
Immunomodulators [azathioprine, mercaptopurine, methotrexate, MMF]		8 [5, 0, 2, 1]
Systemic corticosteroid [oral prednisolone, intravenous hydrocortisone]		6 [5, 1]
Topical corticosteroid		4
5ASA		20
Topical 5ASA		2
No IBD meds		3